2C-P

Current official national law expressly controls 2C-P in United States; unauthorized possession, supply, or manufacture is prohibited.

Current NPSV § 1(1) Z 2 includes every substance covered by an Anlage II chemical definition, and Anlage II Z 2 covers every compound derivable from a phenethylamine basic structure, including compounds with chemical structures listed in § 1(2) as substituents. PubChem identifies 2C-P as 2-(2,5-dimethoxy-4-propylphenyl)ethanamine, which directly supplies the phenethylamine core and dimethoxy/propyl substitutions. The current SV text and Annex V contain no 2C-P entry: Annex V expressly names several other 2C compounds (2C-B, 2C-I, 2C-T-2 and 2C-T-7), and 2C-P is not individually listed as a Suchtgift. NPSG § 2 excludes substances subject to the Suchtmittelgesetz and lawfully marketed medicines from the NPSG; inclusion in the NPSV generic class does not establish 2C-P's classification as an SMG Suchtgift. For a covered NPS, NPSG § 4(1) criminalizes for-profit manufacture, import, export, transfer or provision when intended for another person's or a third party's psychoactive use, with up to two years' imprisonment; § 4(2) provides one to ten years where the offence causes death or serious injury to a larger number of people. NPSG § 5 provides confiscation and says that, for StPO procedure, an NPS is treated as an object whose possession is generally prohibited, but that wording does not establish that every personal possession circumstance is independently a § 4 offence. If 2C-P is an SMG Suchtgift, SMG § 27 provides that unauthorized acquisition, possession, manufacture, transport, import/export, offer, transfer or provision of a Suchtgift carries up to one year or 360 daily rates, with up to six months or 360 daily rates for conduct exclusively for personal use; higher maxima apply to specified aggravated conduct. 2C-P's classification as an SMG Suchtgift remains unresolved, and a medicine-law exception may apply in a particular case.

Current official national law expressly controls 2C-P in Canada; unauthorized possession, supply, or manufacture is prohibited.

The official government publication names parent 2C-P and provides the prohibition rule.

2C-P is expressly listed in Danish List B and is subject to the regulation's authorization/medical exceptions.

Current official national law expressly controls 2C-P in Germany; unauthorized possession, supply, or manufacture is prohibited.

The MHLW current designated-substances schedule lists 2C-P as a designated substance, not as a narcotic or psychotropic. The current MHLW narcotics schedule and statutory and decree psychotropics schedules contain no 2C-P or matching chemical-name entry. Under PMD Act Article 76-4, the listed substance and its salts may not be manufactured, imported, sold, transferred, possessed, purchased, received, or used for purposes other than the statutory medical等用途 (medical diagnosis, treatment or prevention, or other ministerially specified uses that do not risk harm to the human body). This is a general non-medical prohibition, not a prescription-only classification; the medical等用途 exception does not make ordinary recreational possession or use lawful. For a non-business violation, Article 84(28) provides up to three years' 拘禁刑 (拘禁刑; the current statutory custodial penalty) or a fine up to ¥3,000,000, or both. Business manufacture, import, sale, transfer, or possession for sale/transfer (storage or display for that purpose) is separately covered by Article 83-9 and carries up to five years' 拘禁刑 or a fine up to ¥5,000,000, or both. These are statutory maximums.

The current structural rule covers aromatic-ring substitution, including the propyl substituent in 2C-P.

2C-P is currently controlled. The current List IA generic 2-phenethylamine group covers its 2-phenylethan-1-amine core and its 2,5-dimethoxy-4-propyl phenyl substitution (alkoxy and alkyl substituents up to C6). Article 2a(1) prohibits import/export, preparation, processing, sale, delivery, supply, transport, possession and manufacture of covered substances or preparations. Article 2a(2) exceptions remain applicable, including authorized medicines, veterinary products, registered precursors and other listed exceptions.

The official Gazette decision expressly identifies 2C-P as item 1(b) under "Fenetilamin grubu maddelerden" and states that the annexed substances are made subject to Law No. 2313 pursuant to Article 19. The Turkish Narkotic Suçlarla Mücadele Başkanlığı's 2011 national report records that 2C-P was among the substances made subject to Law 2313 by the 13 February 2011 Gazette decision, and explains that the Article 19 process places a newly identified psychoactive substance under the law through a Health Ministry proposal and Council of Ministers decision. The 2025 Türkiye Uyuşturucu Raporu describes Law No. 2313 as one of Turkey's core drug-control statutes, identifies TCK Article 188 as the manufacture/trade provision and Article 191 as the provision covering use or possession for use, and reports that 1,078 NPS had been brought within Law 2313 through 31 July 2025. TCK Article 188(1) covers unlicensed or unauthorized manufacture, import or export; Article 188(3) covers domestic sale, offering, giving, dispatch, transport, storage, purchase, acceptance or possession; and Article 191(1) covers buying, accepting, possessing or using for personal use. The TCK gives the currently published penalty ranges. The Article 188(4)(a) half-increase for amphetamine and derivatives is not established for 2C-P merely because 2C-P is listed under the phenethylamine heading. The official schedule decision does not describe a medical, research, licensing or quantity exception; any authorization or exception is determined under the operative Turkish legislation for the particular conduct. The official Gazette decision contains the 2011 exact-name listing, and the national NPS-control framework continued through 31 July 2025.

Current official national law expressly controls 2C-P in United Kingdom; unauthorized possession, supply, or manufacture is prohibited.

2C-P is expressly listed as 2-(2,5-dimetoksi-4-(n)-propyylifenyyli)etaaniamiini in the annex to Valtioneuvoston asetus 1130/2014 as a psychoactive substance banned from the consumer market. Under Huumausainelaki 373/2008, its manufacture, import into Finland, storage, offering for sale and supply are prohibited; possession and use are not included in this category-specific prohibition. Exceptions apply to qualifying research and industrial activities under section 23 b of the Act. The listing has applied since 20 December 2014 and remains in the current annex replaced by Decree 650/2026, effective 10 July 2026.

The applicable category is Verzeichnis e. BetmVV-EDI lists 2C-P and supplies its chemical designation in Annex 6 item 10. BetmVV-EDI Article 1(2)(a) treats Annex 1–6 entries as controlled substances and Article 2(2) places Verzeichnis e in Annex 6. BetmKV Article 3(2)(e) subjects Verzeichnis-e entries to the control measures applicable to Verzeichnis-a narcotics, Article 5(2) assigns the operating permit for handling them to the EDI, and Article 11(1) requires an operating permit for listed handling activities including manufacture, obtaining, brokering, import/export, supply and trade. BetmG Article 7(1) requires EDI authorization and compliance with its conditions for cultivating, manufacturing, importing, exporting, storing, using or placing Article 7 materials/products into circulation; Article 20(1)(c) provides up to three years' imprisonment or a monetary penalty for specified unauthorized conduct involving Article 7 substances/products. 2C-P is subject to permit-based restrictions; it is not in Verzeichnis d, and not every possible act is categorically prohibited. The exact-name schedule entry does not state a separate 2C-P-specific exemption.